My dad is still clueless why he was attacked: Justice Shetty's son

Mangaluru, Apr 5: As the number of Covid 19 cases continue to spike across Karnataka, there are patients who are recovering from this deadly virus as well. The first case of Covid 19 detected in Mangaluru has fully recovered and all set to return home.

The first case of corona infection was reported on March 22 in Dakshina Kannada district. 

A 22-year-old youth hailing from Bhatkal had landed at Mangaluru International Airport on March 19. 

As he was suffering from mild fever and cold, he was quarantined in Mangaluru. He had come from Dubai.

His throat swabs were sent for testing on the same day and on March 22 he was tested positive for coronavirus. 

He has undergone 14-day long treatment at the Wenlock Hospital, Mangaluru. 

On April 2 and 3, his throat swabs were sent for testing again. Both times he was tested negative for coronavirus. He is expected to be discharged on April 6.

So far a dozen coronavirus positive cases have been confirmed in Dakshina Kannada. With the recovery of one patient, there are 11 active cases in the district.

Bengaluru, May 22: Karnataka government on Thursday announced that weddings scheduled for May 24 and May 31 are exempted from complete lockdown on Sundays.

As per an earlier advisory issued by the State government with regard to weddings, not more than 50 guests shall be allowed and the consumption of liquor on the occasion will be prohibited.

According to the advisory, sanitisers should be provided at the entry and other appropriate places at the venue. Also, thermal screening of all persons shall be conducted at the entry of the venue. The scanner should be held 3-15 cms away from a person's forehead.

Apart from this, the venue shall be "clean and hygienic," and a "nodal person shall be identified for overseeing the arrangements and coordination at the venue."

Also, a list of attendees with contact details has to be maintained and all guests should have downloaded Aarogya Setu app.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.